{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:36:58Z","timestamp":1788050218243,"version":"build-2784847793"},"reference-count":0,"publisher":"American Society of Hematology","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>The c-MYC (MYC) oncogene is a critical driver of multiple myeloma (MM), however, direct targeting of the MYC protein has proven challenging due to its intrinsic structural disorder. In this study, we evaluated the biological activity and molecular mechanism of a ribonuclease-targeting chimera (RiboTAC) designed to promote the degradation of MYC mRNA (MYC-RiboTAC) across a panel of primary patient MM samples and MM cell lines. This heterobifunctional molecule consists of a small molecule targeting the MYC internal ribosomal entry site (IRES) conjugated to a small-molecule recruiter of endogenous RNaseL. The MYC-RiboTAC reduces MYC mRNA and protein levels in an RNase L-dependent manner, selectively inhibits MYC-driven transcriptional programs, and exhibits potent anti-MM activity. It effectively suppresses cell growth in MM cells co-expressing MYC and RNase L, even in the presence of the protective bone marrow. Furthermore, it synergizes with clinically active agents such as carfilzomib, lenalidomide, and pomalidomide. Importantly, MYC-RiboTAC displays favorable safety and pharmacokinetic profiles in mice and significantly suppresses tumor growth in NOD SCID mice bearing MM xenografts, as shown in two different models. These findings highlight the potential of RNA degraders to target mRNAs encoding \"undruggable\" proteins such as MYC, offering a promising avenue for precision cancer therapy<\/jats:p>","DOI":"10.1182\/blood.2026033241","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:59:56Z","timestamp":1785369596000},"update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["A first-in-class RNA degrader reduces c-MYC expression and myeloma cell survival in preclinical models"],"prefix":"10.1182","author":[{"given":"Domenico","family":"Maisano","sequence":"first","affiliation":[{"name":"Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tenghui","family":"Wang","sequence":"additional","affiliation":[{"name":"The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Department of Chemistry, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9400-690X","authenticated-orcid":false,"given":"Steffen Benham","family":"Kulp","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School. 02215 Boston, MA, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa Katia","family":"Favasuli","sequence":"additional","affiliation":[{"name":"Candiolo Cancer Institute, FPO-IRCCS, Candiolo (TO), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuquan","family":"Tong","sequence":"additional","affiliation":[{"name":"The Scripps Research Institute, Jupiter, Florida, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8229-3047","authenticated-orcid":false,"given":"Michela","family":"Cumerlato","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chungen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9295-4084","authenticated-orcid":false,"given":"Francesca","family":"Barello","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8760-1794","authenticated-orcid":false,"given":"Marcello","family":"Turi","sequence":"additional","affiliation":[{"name":"Candiolo Cancer Institute FPO-IRCCS, Candiolo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Rampa","sequence":"additional","affiliation":[{"name":"INOC - Istituto Nazionale Oncologico Candiolo, Candiolo (TO), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9478-920X","authenticated-orcid":false,"given":"Rosa Alba","family":"Parisi","sequence":"additional","affiliation":[{"name":"Candiolo Cancer Institute, FPO-IRCCS, Candiolo (TO), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5548-1564","authenticated-orcid":false,"given":"Filip","family":"Garbicz","sequence":"additional","affiliation":[{"name":"Broad Institute of MIT and Harvard, 415 Main St, Cambridge, MA 02142, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ladisa","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7494-0154","authenticated-orcid":false,"given":"Giulia","family":"Giorgetti","sequence":"additional","affiliation":[{"name":"Clinic of Hematology, Department of Internal Medicine and Medical Specialties (DiMI), University of Genoa, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandraditya","family":"Chakraborty","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1387-6129","authenticated-orcid":false,"given":"Laure","family":"Vreux","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Sangiorgio","sequence":"additional","affiliation":[{"name":"Candiolo Cancer Institute, FPO-IRCCS, Candiolo (TO), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6958-5698","authenticated-orcid":false,"given":"Ivana","family":"Sarotto","sequence":"additional","affiliation":[{"name":"Candiolo Cancer Institute FPO-IRCCS, Candiolo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0183-0562","authenticated-orcid":false,"given":"Anil","family":"Aktas Samur","sequence":"additional","affiliation":[{"name":"Dana Farber Cancer Institution, Boston, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet K.","family":"Samur","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben D.","family":"Carrasco","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariateresa","family":"Fulciniti","sequence":"additional","affiliation":[{"name":"Dana Farber Cancer Institute, Boston, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3154-4775","authenticated-orcid":false,"given":"Michael D","family":"Cameron","sequence":"additional","affiliation":[{"name":"The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, Florida, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth C.","family":"Anderson","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Boston, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Gulla","sequence":"additional","affiliation":[{"name":"Istituto nazionale Oncologico Candiolo INOC, Candiolo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7829-3240","authenticated-orcid":false,"given":"Jessica","family":"Childs-Disney","sequence":"additional","affiliation":[{"name":"The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Department of Chemistry, Jupiter, Florida, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Disney","sequence":"additional","affiliation":[{"name":"The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Department of Chemistry, 130 Scripps Way, Jupiter, FL 33458, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8850-0442","authenticated-orcid":false,"given":"Eugenio","family":"Morelli","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Torino, Candiolo (TO), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil C.","family":"Munshi","sequence":"additional","affiliation":[{"name":"VA Boston Healthcare System; Boston, MA, 02132, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,7,29]]},"container-title":["Blood Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/doi\/10.1182\/blood.2026033241\/2536306\/blood.2026033241.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/doi\/10.1182\/blood.2026033241\/2536306\/blood.2026033241.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:59:56Z","timestamp":1785369596000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/doi\/10.1182\/blood.2026033241\/569967\/A-first-in-class-RNA-degrader-reduces-c-MYC"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1182\/blood.2026033241","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"article-number":"blood.2026033241"}}